Page 364 - Biodegradable Polyesters

342 Index
chicken feather fibers (CFF)/PLA composites electrospinning-electrospraying 174
329 electrosprayed electrospun drug/biopolymer
chitosan(CS)/PCL vascular scaffolds 174 nanofibers 289–292
CKAs, see cyclic ketene acetals (CKAs) electrospraying 175
coated metal stents (CMSs) 301 electrospun PLA: PCL fiber mats
coaxial electrospun drug/biopolymer – apparatus setup 194
nanofibers 286 – biodegradability 207, 208
– core-shell structured fibers 284, 285 – blend ratio 198, 202
– porous core/sheath structured composite – co-solvents 193, 200, 201
nanofibers 285 – drug delivery 191
– PVP/zein 283 – DSC data 196, 203, 204
coconut fibers/PLA 329 – FTIR spectra 197, 205
co-electrospinning 174 – material formulations 195
cold-crystallization 116–118 – nanofibre diameters 200, 201
collagen 173 – SEM micrographs 199, 202
compostability 235 – solution viscosity 196, 197, 200, 201
condensation polymerization 1, 5 – tetracycline hydrochloride (TCH) drug
conetworks 145, 146 release rate 197, 206
controlled radical polymerization 31 – XRD analysis 196, 202, 203
cotton fibers/PLA composites 328 electrospun polyester scaffolds
craze morphology 245 – bioactive molecules 170–172, 179
cumulative drug release rate 196 – biocompatibility improvement, see surface
cyclic ketene acetals (CKAs) 26, 27 functionalization
– controlled radical polymerization 31 – biodegradable polyesters, preparation of
– synthetic scheme 26 156, 157, 159
– unsaturated polyesters 30 – co-electrospinning 174
cyclophosphamide-loaded gliadin – electrospraying-electrospinning 174, 175
nanoparticles 290 – gelatin/PGA blend 173
– hydroxyapatite 173
d – plasma treatment 162, 164, 165
debonded morphology 247 – PLCL/collagen nanofibers 173
Degussa method 76 – pretreatments 172–175
DESs, see drug-eluting stents (DESs) – production techniques 156
Diels-Alder reactions 137, 138, 141 – spirulina 173
D-lactic acid 110 – surface functionalization, see surface
3-D nanoporous nanhofibrillar network 225, functionalization
227, 232 – tissue engineering 155, 176, 177
drug-eluting stents (DESs) 301 – UV radiation 167, 170
drug-loaded biopolymer nanofibers –UV-ozone (UV/O ) treatment 165–167
3
– multi-component 279, 280 – wet chemical surface modification 160,
– nanoparticles 280–283 162
– single-component 277–279 emulsification 218
emulsion electrospinning 178
e emulsion electrospun drug/biopolymer
E-glass fiber reinforced composites 324, 327 nanofibers 287
EAC, see ethylene/acrylate copolymer (EAC) – BSA molecules 287
EBA-GMA, see ethylene/n-butyl – core-shell structures 286
acrylate/glycidyl methacrylate terpolymer – doxorubicin hydrochloride (DOX) 286
(EBA-GMA) – hydroxycamptothecin (HCPT) 287
electro-active SMPs 135 – pDNA polyplexes 289
electroresponsive SMPs 144 – polymeric drug carriers 286
electrospinning 191–194, 198, 201, 203, 206, enzyme-assisted photolithography (EAPL)
221, 275, 292 168
– experimental setup 276 epoxy (EP) -PCL conetworks 146